Article Details

FDA OKs third antibody COVID therapy; variants spur new pause on another

Retrieved on: 2021-05-31 22:18:03

Tags for this article:

Click the tags to see associated articles and topics

FDA OKs third antibody COVID therapy; variants spur new pause on another. View article details on hiswai:

Excerpt

A new COVID-19 treatment made by GlaxoSmithKline now is the third ... virus variants, although its combination therapy remained in use at the time. ... by some geriatricians and industry advocates as a boon for long-term care ...

Article found on: www.mcknights.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up